University at Buffalo - The State University of New York
Skip to Content
Official UB news and information for the media

Renowned oncologist Marc Ernstoff to assume leadership roles at UB, Roswell Park

Ernstoff has previously held positions at the Cleveland Clinic, Dartmouth's Geisel School of Medicine and the University of Pittsburgh School of Medicine.

Melanoma expert named UB chief of Hematology/Oncology, Roswell Park chair of medicine

Release Date: February 5, 2016

Ernstoff comes to UB and Roswell Park from the Cleveland Clinic's Taussig Cancer Institute, where he is director of the Melanoma Program.

BUFFALO, N.Y. – Marc S. Ernstoff, MD, has been appointed professor and chief of the Division of Hematology/Oncology in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB), and chair of the Department of Medicine and senior vice president of clinical investigation at Roswell Park Cancer Institute (RPCI). Ernstoff also will serve as chief of the Division of Hematology/Oncology at UBMD Internal Medicine, the clinical practice plan of the UB Department of Medicine.

The appointments take effect on April 1.

“We are extremely pleased that Dr. Ernstoff will be joining the Department in a leadership role in the Division of Hematology/Oncology,” said Anne B. Curtis, MD, UB Distinguished Professor and Charles and Mary Bauer Professor and Chair of the Department of Medicine. “His joint appointment as Chief of the Division of Hematology/Oncology at the Jacobs School of Medicine and Biomedical Sciences at UB and chair of medicine at Roswell Park is a clear indication of the close collaboration we have between the two institutions. We look forward to working with Dr. Ernstoff to build clinical, educational, and research programs at Roswell Park, as well as with UB and UBMD Internal Medicine.”

“I’ve known Dr. Ernstoff as a colleague and collaborator, and I admire him tremendously. He’s one of the most inspiring leaders I know in oncology, and his accomplishments in every arena — clinical, academic and research — represent the best work being done today in our field,” said Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute. “He is going to do great things for cancer patients, locally and far away from Western New York.”

In 2014, Ernstoff became the director of the Melanoma Program at Cleveland Clinic’s Taussig Cancer Institute. From 1991 to 2014, he served as associate professor of medicine and professor of medicine at Dartmouth College’s Geisel School of Medicine and Dartmouth-Hitchcock Medical Center. During much of his tenure, Ernstoff was the director of the Melanoma Program at the Norris Cotton Cancer Center and the section chief of Hematology/Oncology.

Ernstoff was previously a faculty member at the University of Pittsburgh’s School of Medicine, where he directed the Hematology/Oncology fellowship training program; he also was an assistant professor of medicine at Yale University and director of its Clinical Research Office.

Ernstoff’s clinical research is focused on the treatment of melanoma and genitourinary cancers. A member of the National Comprehensive Cancer Network Melanoma Committee, he is also a member of the International Melanoma Working Group.

A Brooklyn, N.Y., native, he completed his undergraduate degree at Emory University and earned his MD from New York University. He completed his residency in internal medicine at the Bronx Municipal Medical Center and the Albert Einstein College of Medicine and a medical oncology fellowship at the Yale University School of Medicine. Ernstoff is board certified in internal medicine and medical oncology.

 

Media Contact Information

Ellen Goldbaum
News Content Manager
Medicine
Tel: 716-645-4605
goldbaum@buffalo.edu
Twitter: @UBmednews